World Orphan Drug Congress USA 2018
community download

World Orphan Drug Congress 2018 Invitae Whitepaper

Invitae’s genetic testing and patient engagement programsremove barriers to diagnosis and bring new therapies to market sooner


Invitae has partnered with biopharmaceutical companies and advocacy organizations to develop novel programs to address challenges in the diagnostic journey. These programs play a pivotal role in the diagnosis and management of rare disease by removing barriers to genetic testing and making patients and their clinicians aware of clinical trials and research that bring new treatments to market. 
The abstract details the Behind the Seizure program with BioMarin in pediatric epilepsy and the Mast Cell Connect patient registry with Blueprint Medicines in systemic mastocytosis.  
To learn more about Invitae, visit our website here.  

Some quick details

Email Address:*
First name:*
Last name:*
Job Title:*

Remember my details Information

Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Privacy statement »
Manage your email preferences »

You will be emailed the document as an attachment (267Kb in size)